387 filings
10-Q
2024 Q2
NVOS
Novo Integrated Sciences Inc
Quarterly report
15 Apr 24
4:35pm
8-K
NVOS
Novo Integrated Sciences Inc
15 Apr 24
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
4:30pm
8-K
NVOS
Novo Integrated Sciences Inc
11 Apr 24
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
5:00pm
8-K
NVOS
Novo Integrated Sciences Inc
10 Apr 24
Unregistered Sales of Equity Securities
5:00pm
8-K
NVOS
Novo Integrated Sciences Inc
26 Mar 24
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
2:30pm
8-K
l75qmv6cv5zo
19 Mar 24
Entry into a Material Definitive Agreement
4:05pm
8-K
vy02 nim0rcew
18 Mar 24
Entry into a Material Definitive Agreement
3:30pm
8-K
kmz0wev4v
21 Feb 24
Regulation FD Disclosure
4:05pm
8-K
fto6j973
20 Feb 24
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
2:00pm
8-K
671um
16 Feb 24
Novo Integrated Sciences Appoints New President
2:00pm
8-K
gry1mhavf 198n
15 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
ugd q7a4i8
22 Jan 24
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
4:30pm
NT 10-Q
7bj285v9
16 Jan 24
Notice of late quarterly filing
4:05pm
8-K
42r2633
19 Dec 23
Regulation FD Disclosure
4:45pm
8-K
7247 av0xto1nymeu
14 Dec 23
Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results
5:00pm
8-K
deqjilenzuq5xtw
5 Dec 23
Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India
1:20pm
8-K
wpqz15qv
4 Dec 23
Novo Integrated Sciences’ Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval
11:30am
NT 10-K
f3zjr23hj 44blnf2rt
29 Nov 23
Notice of late annual filing
4:05pm